Excellent point and I was thinking about this yesterday.....
Anybody, including say Johnson&Johnson, who gets on the front foot with partnering or buying The DurAVR TAVR technology will also implicitly be the frontrunner to buy or partner the v2v mitral valve repair technology..... very smart move by Wayne Paterson and the team.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.85 |
Change
0.000(0.00%) |
Mkt cap ! $75.19M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 368 | $4.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.00 | 836 | 1 |
View Market Depth
| Last trade - 10.00am 28/07/2025 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable